Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
| Status: | Archived |
|---|---|
| Conditions: | Arthritis, Gout, Orthopedic |
| Therapuetic Areas: | Rheumatology, Orthopedics / Podiatry |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | December 2010 |
| End Date: | November 2011 |
A Randomized, Double-Blind, Dose-Response Study of the Safety and Efficacy of Oral BCX4208 Added to Allopurinol in Subjects With Gout Who Have Not Adequately Responded to Allopurinol Monotherapy
The purpose of this study is to determine whether BCX4208 and allopurinol combined for 12
weeks are effective in treating gout in patients who are not adequately responding to
allopurinol alone.
We found this trial at
26
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials